Novavax, Inc. is a global biotechnology company committed to helping address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world.

Our mission

We never rest in our quest to protect the health of people everywhere.

Novavax is here to make a difference. We're a biotech company focused solely on developing life-saving vaccines to fight infectious diseases.

Our commitment is backed by solid science tested by decades of research, vaccines developed from trusted technology and a global network that will help to ensure our vaccines reach everyone who needs them.

Select local leaders
Alvar Paz
Alvar Paz
General Manager,
Commercial Strategy,
Peter Mitterhofer
Peter Mitterhofer
Head of DACH cluster,
Commercial Operations,
Dirk Poelaert
Dirk Poelaert
Senior Director,
Medical Affairs,
Novavax in Europe

Novavax AB
Novavax AB is located in Uppsala, Sweden. This facility is responsible for research, development and production of our saponin-based adjuvants. Our Matrix-MTM is used in multiple vaccine candidates to enhance the immune response and stimulate high levels of neutralizing antibodies.

Novavax CZ
In 2020, Novavax CZ, located in Bohumil, the Czech Republic was established. The facility is a state-of-the-art vaccine and biologics manufacturing campus dedicated to producing vaccines that help protect global health.

Novavax EU
Starting 2022, Novavax started to develop commercial hubs throughout Europe with the regional main office in Zurich, Switzerland. Additional offices are now established also in Brussels, Belgium and Barcelona, Spain.

Novavax office locations in Europe
How to contact Novavax
General inquiries

+49 800 1813940
09:00 - 17:00
Monday - Friday

More information is available on our global website,

Our location: 
Novavax CH GmbH
C/o Regus
Brüsseler Straße 1-3
60327 Frankfurt am Main

Media contact
Investor contact

To contact a member of the investor relations team, click on the "Contact us" button below.